http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
本態性高血壓患者에 대한 Long acting propranolol(Inderal L.A.^ⓡ)의 臨床效果
金宏植,林正根,林慶浩,劉元相 인제대학교 1982 仁濟醫學 Vol.3 No.2
저자들은 20명의 本態性高血壓患者에게 Long acting propranolol 1日 1回 投與하고 그 降壓 및 心搏數의 減少效果를 propranolol 1日 2-4回 投與한 效果와 比較하였던 바 그 效果는 同等했고, 副作用은 심하지 않았다. The effect of long acting propranolol (Inderal L.A.R) given once daily has been compared with conventional propranolol(Inderal L.A.R) given three to four times daily in twenty patients with essential hypertension. The study consisted of 3 phases (Phase 1 : conventional propranolol, Phase 2 : Long acting propranolol, Phase 3 : conventional propranolol) and lasted 10 weeks. There was no significant difference in lowering of blood pressure and reduction of heart rate between two treatment, which were equally effective and well tolerated. Thus once-daily-dosage schedule should greatly improve patient's compliance.
김굉식,이건주,김철수,이영구,강영석 인제대학교 1982 仁濟醫學 Vol.3 No.4
혈액형의 후천적 변화는 백혈병을 포함한 여러 질환에서 보고가 있었다. 저자들은 급성 골수성 백혈병 환자 일례에서 일신적인 A항원의 소실을 경험하였기에 문헌 고찰과 함께 보고하는 바이다. A 28 years old woman with acute myelogenous leukemia received many units of blood during remission induction period, and her blood was typed as group "O". However, when her leukemia went into remission, her blood group was turned out to be "A". This case illustrates temporary loss of red cell blood group "A" antigen in acute myelogenous leukemia.